Risks and Benefits of Disease-Modifying Therapies in People Aging With Multiple Sclerosis
More data are needed to ascertain the actual risks and benefits of DMT use, discontinuation, and de-escalation in older people with MS.
Comorbidity, Polypharmacy, and Aging in Multiple Sclerosis
Comprehensive care addressing issues that are common in older people with MS, including polypharmacy and comorbidity, may improve quality of life, adherence, and overall health.
In people with multiple sclerosis, greater resilience was associated with more physical activity, which in turn was connected to better functional capabilities. Resilience did not directly impact functioning after considering factors such as mood and fatigue.
Short Report: Adherence to Neuropsychological Recommendations in Patients with Multiple Sclerosis